Uploaded February 2025 | Updated November 2026, 10 hours ago
Tom Rapoport, Ph.D., joined the faculty at Harvard Medical School in 1995. He received his Ph.D. in Biochemistry from the Humboldt University in East-Berlin for work in enzymology. He then focused on mathematical modeling of metabolism, for which he received his second degree (Habilitation) from the same institution. Before moving to the US, he worked at the Central Institute of Molecular Biology of the Academy of Sciences of the GDR and later at the Max-Delbrueck Center for Molecular Medicine in Berlin-Buch. In 1997, he became a Howard Hughes Medical Institute Investigator.
For more information go to oir.nih.gov/wals/current-lecture-season
Tom Rapoport, Ph.D., joined the faculty at Harvard Medical School in 1995. He received his Ph.D. in Biochemistry from the Humboldt University in East-Berlin for work in enzymology. He then focused on mathematical modeling of metabolism, for which he received his second degree (Habilitation) from the same institution. Before moving to the US, he worked at the Central Institute of Molecular Biology of the Academy of Sciences of the GDR and later at the Max-Delbrueck Center for Molecular Medicine in Berlin-Buch. In 1997, he became a Howard Hughes Medical Institute Investigator.
For more information go to oir.nih.gov/wals/current-lecture-season









![Harnessing African Genomic Variations to Improve Health and Equity Globally
Air date: Wednesday, September 14, 2022, 2PM
Description: NIH Director’s Wednesday Afternoon Lecture Series [WALS ]
Prof Ambroise Wonkam is a professor of Genetic Medicine, and Director of the McKusick-Nathans Institute, and Department of Genetic Medicine. After an MD training from the Faculty of Medicine and Biomedical Sciences, University of Yaoundé I (Cameroon), he completed a thesis in Medical Sciences, University of Geneva (Switzerland) and a Ph.D. in Human Genetics (University of Cape Town, South Africa). Other salient aspects of Prof Wonkam’s background include his education as a medical geneticist at a highly reputable genetics department in Geneva (Switzerland). He subsequently practices medical genetics in both European and African contexts.
African genomes harbor millions of uncaptured variants accumulated over 300,000 years of modern humans evolutionary history, with successive waves of admixture, migration, and natural selection combining with extensive ecological diversity to create a broad and exceptional genomic complexity. Therefore to embrace the prospects of accurately diagnosing thousands of monogenic conditions, predicting disease risks for complex traits or diseases, tailoring treatment to individuals pharmacogenetic profiles, and potentially curing some diseases, research into African genomic variation is a scientific imperative.
For more information go to https://oir.nih.gov/wals
Author: Ambroise Wonkam, M.D., Ph.D., Hopkins Medicine
Permanent link: https://videocast.nih.gov/watch=45982 Harnessing African Genomic Variations to Improve Health and Equity Globally](https://i.ytimg.com/vi/bNuUluhiozI/mqdefault.jpg)
